Colin W Taylor Selected Research

glycylphenylalanine 2-naphthylamide

1/2019

GPN does not release lysosomal Ca2+ but evokes Ca2+ release from the ER by increasing the cytosolic pH independently of cathepsin C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colin W Taylor Research Topics

Disease

1	Rupture 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2017
1	Hypertension (High Blood Pressure) 10/2016
1	Neoplasms (Cancer) 04/2016
1	Osteoporosis 02/2012
1	Mycoses (Diseases, Fungus) 01/2012
1	Insulinoma 02/2009

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 04/2016 - 02/2012
1	Cathepsin CIBA 01/2019
1	DipeptidesIBA 01/2019
1	EnzymesIBA 01/2019
1	glycylphenylalanine 2-naphthylamideIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	ChemokinesIBA 10/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2016
1	Ion Channels (Ion Channel)IBA 04/2016
1	SteroidsIBA 04/2016
1	Psychotropic Drugs (Psychoactive Drugs)IBA 04/2016
1	Anabolic AgentsIBA 02/2012
1	Parathyroid Hormone-Related ProteinIBA 02/2012
1	RyanodineIBA 02/2009
1	Caffeine (No Doz)FDA LinkGeneric 02/2009

Therapy/Procedure

1	Therapeutics 01/2012